Benzinga | Apr 6, 2021 09:30AM EDT

UBS Initiates Coverage On ALX Oncology Holdings with Buy Rating, Announces Price Target of $96

UBS analyst Colin Bristow initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Buy rating and announces Price Target of $96.